Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (31-40 of 922) with videos related to

Pageof 93
Sort By:
Annals of Translational Medicine|August 25, 2021
Narrative Review of Carotid disease and the kidneyLuca Zanoli, Dimitri P Mikhailidis
Angiology|May 25, 2021
Perivascular Adipose Tissue: Pathophysiological Links With Inflammation, Atherosclerosis, and ThrombosisNiki Katsiki, Dimitri P Mikhailidis
Current Opinion in Cardiology|June 1, 2023
Editorial: from albuminuria to uric acid - emerging risk factors beyond lipidsDebabrata Mukherjee, Dimitri P Mikhailidis
Current Medical Research and Opinion|July 29, 2008
Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice studyZlatko Fras, Dimitri P Mikhailidis
Diabetes Care|March 23, 2017
Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692Niki Katsiki, Dimitri P Mikhailidis
Anatolian Journal of Cardiology|February 2, 2017
Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?Niki Katsiki, Dimitri P Mikhailidis
Journal of Diabetes and Its Complications|September 17, 2019
Iron absorption, bone marrow fat and hematopoiesis in heart failure: Additional mechanisms of action for sodium-glucose co-transporter 2 inhibitors (SGLT2i)?Niki Katsiki, Dimitri P Mikhailidis
Current Vascular Pharmacology|July 29, 2020
Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease)Zlatko Fras, Dimitri P Mikhailidis
Expert Opinion on Pharmacotherapy|July 23, 2020
Impact of glucagon-like peptide 1 receptor agonists and sodium-glucose transport protein 2 inhibitors on blood pressure and lipid profileEmir Muzurović, Dimitri P Mikhailidis
International Journal of Cardiology|July 10, 2002
Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studiesAnthony S Wierzbicki, Dimitri P Mikhailidis
Pageof 93

Showing results (31-40 of 922) with videos related to

Sort By:
Pageof 93
Annals of Translational Medicine|August 25, 2021
Narrative Review of Carotid disease and the kidneyLuca Zanoli, Dimitri P Mikhailidis
Angiology|May 25, 2021
Perivascular Adipose Tissue: Pathophysiological Links With Inflammation, Atherosclerosis, and ThrombosisNiki Katsiki, Dimitri P Mikhailidis
Current Opinion in Cardiology|June 1, 2023
Editorial: from albuminuria to uric acid - emerging risk factors beyond lipidsDebabrata Mukherjee, Dimitri P Mikhailidis
Current Medical Research and Opinion|July 29, 2008
Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice studyZlatko Fras, Dimitri P Mikhailidis
Diabetes Care|March 23, 2017
Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692Niki Katsiki, Dimitri P Mikhailidis
Anatolian Journal of Cardiology|February 2, 2017
Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?Niki Katsiki, Dimitri P Mikhailidis
Journal of Diabetes and Its Complications|September 17, 2019
Iron absorption, bone marrow fat and hematopoiesis in heart failure: Additional mechanisms of action for sodium-glucose co-transporter 2 inhibitors (SGLT2i)?Niki Katsiki, Dimitri P Mikhailidis
Current Vascular Pharmacology|July 29, 2020
Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease)Zlatko Fras, Dimitri P Mikhailidis
Expert Opinion on Pharmacotherapy|July 23, 2020
Impact of glucagon-like peptide 1 receptor agonists and sodium-glucose transport protein 2 inhibitors on blood pressure and lipid profileEmir Muzurović, Dimitri P Mikhailidis
International Journal of Cardiology|July 10, 2002
Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studiesAnthony S Wierzbicki, Dimitri P Mikhailidis
Pageof 93